Market Closed - Nyse 21:00:03 21/06/2024 BST 5-day change 1st Jan Change
81.64 USD +1.83% Intraday chart for Medtronic plc +0.74% -0.90%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sempra Appoints Jennifer M. Kirk to Board of Directors CI
Endologix LLC Appoints Graham Phillips as Chief Operating Officer CI
Medtronic Insider Sold Shares Worth $1,601,001, According to a Recent SEC Filing MT
Transcript : Medtronic plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM
Medtronic plc Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 CI
Medtronic Closes Offering of 3 Billion Euros of Notes MT
Daiwa Securities Adjusts Price Target on Medtronic to $92 From $100 MT
Medtronic Prices 3 Billion Euros Senior Notes Offering MT
Medtronic is hiding behind its status as dividend aristocrat Our Logo
UBS Adjusts Medtronic Price Target to $76 From $75, Maintains Sell Rating MT
Bernstein Adjusts Price Target on Medtronic to $96 From $97 MT
Truist Securities Adjusts Price Target on Medtronic to $88 From $90, Keeps Hold Rating MT
Wolfe Research Adjusts Price Target on Medtronic to $82 From $80 MT
Baird Adjusts Price Target on Medtronic to $87 From $88 MT
Wells Fargo Adjusts Price Target on Medtronic to $105 From $102 MT
Sector Update: Health Care Stocks Retreat Late Afternoon MT
Health Care Limits Losses Amid Defensive Bias - Health Care Roundup DJ
Sector Update: Health Care Stocks Lower Thursday Afternoon MT
Sector Update: Health Care MT
Piper Sandler Adjusts Medtronic's Price Target to $85 From $87, Keeps Neutral Rating MT
Some of the biggest splits in Corporate America RE
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... Our Logo
Medtronic Guides for Annual Growth in Fiscal 2025 as Fourth-Quarter Results Top Views MT
Medtronic's Fiscal Q4 Non-GAAP Earnings Fall, Net Sales Rise; Fiscal 2025 Guidance Issued; Quarterly Dividend Lifted MT
Chart Medtronic plc
More charts
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
81.64 USD
Average target price
94.07 USD
Spread / Average Target
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. News Medtronic plc
  5. Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development